CIBC Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$148K Sell
24,628
-678
-3% -$5.1K ﹤0.01% 1272
2025
Q4
$181K Buy
25,306
+504
+2% +$3.98K ﹤0.01% 1241
2025
Q3
$265K Hold
24,802
﹤0.01% 990
2025
Q2
$240K Buy
24,802
+55
+0.2% +$567 ﹤0.01% 996
2025
Q1
$368K Sell
24,747
-776
-3% -$11.9K ﹤0.01% 800
2024
Q4
$381K Buy
25,523
+1,184
+5% +$19.3K ﹤0.01% 804
2024
Q3
$466K Sell
24,339
-343
-1% -$7.11K ﹤0.01% 759
2024
Q2
$511K Sell
24,682
-2,097
-8% -$41.7K ﹤0.01% 731
2024
Q1
$503K Sell
26,779
-284
-1% -$4.87K ﹤0.01% 737
2023
Q4
$390K Sell
27,063
-8,030
-23% -$109K ﹤0.01% 759
2023
Q3
$609K Sell
35,093
-495
-1% -$10.3K ﹤0.01% 695
2023
Q2
$741K Sell
35,588
-374
-1% -$8.13K ﹤0.01% 687
2023
Q1
$846K Buy
35,962
+1,018
+3% +$27.3K ﹤0.01% 677
2022
Q4
$976K Sell
34,944
-4,459
-11% -$114K ﹤0.01% 672
2022
Q3
$922K Buy
39,403
+2,931
+8% +$88.5K ﹤0.01% 679
2022
Q2
$1.23M Buy
36,472
+2,412
+7% +$84.5K 0.01% 625
2022
Q1
$1.19M Buy
34,060
+3,865
+13% +$132K ﹤0.01% 660
2021
Q4
$919K Sell
30,195
-193
-0.6% -$6.29K ﹤0.01% 713
2021
Q3
$996K Sell
30,388
-2,396
-7% -$76.7K ﹤0.01% 681
2021
Q2
$992K Buy
+32,784
New +$1.08M ﹤0.01% 688

Other funds holding OGN

CIBC Asset Management's OGN Position: Q1 2026 in Review

CIBC Asset Management reduced its Organon & Co (OGN) stake by 2.7% in Q1 2026, selling an estimated $5.1K and leaving 24,628 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #1272.

CIBC Asset Management first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.23M in Q2 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • CIBC Asset Management held 24,628 shares of Organon & Co worth $148K as of Q1 2026.
  • CIBC Asset Management sold 678 Organon & Co shares in Q1 2026, an estimated $5.1K.
  • Organon & Co made up ﹤0.01% of CIBC Asset Management's portfolio in Q1 2026, its #1272 holding.
  • CIBC Asset Management first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • CIBC Asset Management's Organon & Co position peaked at $1.23M in Q2 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.